Diana Davo-Campillo

Antwerpen, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.

Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.

Journal: Molecular therapy. Nucleic acids
Published: July 12, 2026

IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.

IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.

Journal: Molecular therapy. Oncology
Published: May 08, 2026

Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification.

Increasing Transfection of Human Monocyte-Derived Dendritic Cells by Optimizing Lipid Nanoparticle Ionizable Lipid and mRNA Uridine Modification.

Journal: Pharmaceutics
Published: February 22, 2026

DRP1 depletion protects NK cells from hypoxia-induced dysfunction.

DRP1 depletion protects NK cells from hypoxia-induced dysfunction.

Journal: Redox report : communications in free radical research
Published: February 18, 2026

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

Journal: Experimental hematology & oncology
Published: December 18, 2025

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine.

Journal: Frontiers in immunology
Published: November 28, 2025

Strategies to eliminate native T cell receptors for adoptive T cell therapies.

Strategies to eliminate native T cell receptors for adoptive T cell therapies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 06, 2025

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Journal: Methods in cell biology
Published: March 28, 2024

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Journal: Annals of hematology
Published: March 14, 2024

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

Journal: Journal of hematology & oncology
Published: September 22, 2023

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation.

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation.

Journal: STAR protocols
Published: November 28, 2022

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

Journal: STAR protocols
Published: October 13, 2022
Showing 1-12 of 29

Last Updated: 09/26/2026